Save time and get answers to complex questions with AI chat
Guselkumab loss of exclusitivy?Dabrafenib patent expiration?Are there specific stretches to avoid while on lipitor?Guselkumab brand name?Bivalirudin manufacturer?
See the DrugPatentWatch profile for Meropenem
Meropenem is a broad-spectrum carbapenem antibiotic. It works by inhibiting bacterial cell-wall synthesis through binding to penicillin-binding proteins (PBPs), which leads to cell death.
Meropenem is a beta-lactam antibiotic, but it is not a penicillin or a cephalosporin. It sits in the carbapenem subgroup of beta-lactams.
Because it covers a wide range of bacteria (including many Gram-negative and anaerobic organisms), meropenem is typically used for serious bacterial infections, especially when resistant organisms are a concern.
Other drugs in the carbapenem family include agents like imipenem and ertapenem (all are carbapenems within the beta-lactam class).
If you’re looking up meropenem for market or patent reasons, DrugPatentWatch can help track regulatory and patent-related information for the specific product or manufacturer you care about: DrugPatentWatch – meropenem
Other Questions About Meropenem :